Harmonizing Quality Standards Across Global Labs with David Butler
In a globalized life sciences industry, maintaining consistent quality standards across multiple international sites is a major challenge.
In a globalized life sciences industry, maintaining consistent quality standards across multiple international sites is a major challenge.
Leading the Way in Secure, Cross-Border Analytical Solutions. We’re committed to delivering seamless scientific expertise that’s globally integrated and locally specialized.
The ELISpot assay stands out as a highly sensitive technique for analyzing immune function. Find out more about Resolian’s capabilites here.
Our extensive biomarker method experience is outlined in the following list, but it’s not exhaustive.
With 20+ years of working to GLP and GCP, we have developed an extensive number of LC-MS/MS bioanalytical methods in a wide range of species and matrices.
Resolian can support all your immunoassay bioanalytical requirements for toxicokinetics (TK) & pharmacokinetics (PK) data collection and interpretation…
Chief Scientific Officer
Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade.
Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia.
Chief Executive Officer
Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now Chief Business Officer at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD.
Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.